Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Cytokinetics

(NASDAQ: CYTK)
Add to Portfolio
+0.12 (+1.00%)
as of 11:36 EDT

Last 12.08
Change +0.12 (+1.00%)
Open 12.37
Prev. Close 11.96
Today's Range
11.97
12.66
52wk Range
7.72
16.96
Volume 85832
Avg Volume 883835
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
CYTK +1.00% +0.75% +39.88%
DJIA +4.77% -23.92% -16.54%
S&P 500 +4.72% -20.98% -9.98%

Key Statistics

Annual EPS -2.12
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 716480
Weighted Alpha +47.30
Standard Deviation +0.14
Profit Margin -1489.82%
Beta 1.18

Growth Rates

YTD +14.04%
1-Year +38.27%
3-Year +4.64%
5-Year +64.74%
10-Year -38.10%

Opinion

Sell Hold Buy

Recent Headlines

Cytokinetics Announces Baseline Characteristics from

GlobeNewswire via COMTEX - Mon Mar 30, 07:30AM EDT
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that patient baseline characteristics and demographics from GALACTIC-HF (Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failu(full story)
CYTK: 12.08 (+0.12)

Shares of Acceleron Pharma Rank the Highest in Terms

Comtex SmarTrend(R) via COMTEX - Mon Mar 30, 04:23AM EDT
Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the potential to outperform.(full story)
XLRN: 86.03 (+5.25), BLUE: 43.87 (+1.99), CYTK: 12.08 (+0.12)

Top 5 Companies in the Biotechnology Industry with the

Comtex SmarTrend(R) via COMTEX - Fri Mar 06, 03:29AM EST
Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the potential to outperform.(full story)
CYTK: 12.08 (+0.12), NVAX: 15.21 (-0.40), SGMO: 6.60 (+0.13)

Cytokinetics Granted European Orphan Designation for

GlobeNewswire via COMTEX - Wed Mar 04, 07:30AM EST
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the European Medicines Agency (EMA) has granted orphan medicinal product designation to reldesemtiv for the treatment of amyotrophic lateral sclerosis (ALS). Previousl(full story)
CYTK: 12.08 (+0.12)

Cytokinetics Inc Shares (CYTK)

Comtex SmarTrend(R) via COMTEX - Wed Mar 04, 12:39AM EST
SmarTrend identified a Downtrend for Cytokinetics Inc (NASDAQ:CYTK) on December 13th, 2019 at $10.25. In approximately 3 months, Cytokinetics Inc has returned 38.93% as of today's recent price of $14.24.(full story)
CYTK: 12.08 (+0.12)